Corporate influences on epidemiology
Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand
E-mail: n.e.pearce{at}massey.ac.nz
 |
Abstract |
|---|
Corporate influences on epidemiology have become stronger and more pervasive in the last few decades, particularly in the contentious fields of pharmacoepidemiology and occupational epidemiology. For every independent epidemiologist studying the side effects of medicines and the hazardous effects of industrial chemicals, there are several other epidemiologists hired by industry to attack the research and to debunk it as ‘junk science’. In some instances these activities have gone as far as efforts to block publication. In many instances, academics have accepted industry funding which has not been acknowledged, and only the academic affiliations of the company-funded consultants have been listed. These activities are major threats to the integrity of the field, and its survival as a scientific discipline. There is no simple solution to these problems. However, for the last two decades there has been substantial discussion on ethics in epidemiology, partly in response to the unethical conduct of many industry-funded consultants. Professional organizations, such as the International Epidemiological Association, can play a major role in encouraging and supporting epidemiologists to assert positive principles of how science should work, and how it should be applied to public policy decisions, rather than simply having a list of what not to do.
Keywords Epidemiology, epidemiologic methods, ethics
Accepted 24 April 2007
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Gervas and P. R Mansfield Physicians, the industry and population health J Epidemiol Community Health, October 1, 2009; 63(10): 773 - 774. [Full Text] [PDF]
|
|
|
|
|
|
D. L Weed Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health? J Epidemiol Community Health, August 1, 2009; 63(8): 601 - 602. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pearce and J. Douwes Response: Time for species--course epidemiology? Int. J. Epidemiol., April 1, 2009; 38(2): 403 - 410. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Attaran LLB DPhil, D. R. Boyd LLB, and M. B. Stanbrook MD PhD Asbestos mortality: a Canadian export Can. Med. Assoc. J., October 21, 2008; 179(9): 871 - 872. [Full Text] [PDF]
|
|
|
|
|
|
A. Attaran LLB DPhil, D. R. Boyd LLB, and M. B. Stanbrook MD PhD La mortalite liee a l'amiante : une exportation canadienne Can. Med. Assoc. J., October 21, 2008; 179(9): 873 - 874. [Full Text] [PDF]
|
|
|
|
|
|
N. Pearce Hyping Health Risks: Environmental Hazards in Daily Life and the Science of Epidemiology. Kabat GC. Int. J. Epidemiol., September 18, 2008; (2008) dyn198v1. [Full Text] [PDF]
|
|
|
|
|
|
G. Davey Smith Big business, big science? Int. J. Epidemiol., February 1, 2008; 37(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
J. Haas Commentary: Epidemiology and the pharmaceutical industry: an inside perspective Int. J. Epidemiol., February 1, 2008; 37(1): 53 - 55. [Full Text] [PDF]
|
|
|
|
|
|
A White, N Robinson, P Egger, M Stender, K Davis, J Weil, and S Bowlin Commentary: Collaboration between industry-based and academic epidemiologists Int. J. Epidemiol., February 1, 2008; 37(1): 56 - 57. [Full Text] [PDF]
|
|
|
|
|
|
C. V Phillips Commentary: Lack of scientific influences on epidemiology Int. J. Epidemiol., February 1, 2008; 37(1): 59 - 64. [Full Text] [PDF]
|
|
|
|
|
|
N. Pearce Response: The distribution and determinants of epidemiologic research Int. J. Epidemiol., February 1, 2008; 37(1): 65 - 68. [Full Text] [PDF]
|
|